Telix Pharmaceuticals Ltd business relationships
Companies named in Telix Pharmaceuticals Ltd’s 20-F filed 2026-02-20, and public companies whose annual reports name Telix Pharmaceuticals Ltd. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.1 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Telix Pharmaceuticals Ltd’s annual report 5
“collaboration with Merck KGaA, Darmstadt, Germany.” SEC filing
“In April 2022, we entered into a licensing agreement with Lilly that granted us exclusive worldwide rights to develop and” SEC filing
“distribute Illuccix , including partnerships with Cardinal Health, Inc., PharmaLogic Holdings, Corp., and Jubilant Pharma” SEC filing
“the facility purchased from ImaginAb, Inc. in Los Angeles, completed Stage 1 of the buildout of our European” SEC filing
“distribute Illuccix , including partnerships with Cardinal Health, Inc., PharmaLogic Holdings, Corp., and Jubilant Pharma” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.